Project Grant R01AG090553
Award Date
12/1/24
Completion Date
11/30/29
Dollars Obligated
$817K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Boston, MA 02118, USA
Similar Awards
The National Institute on Aging awarded a 5-year, $6,578,788 Project Grant (CFDA 93.866 - Aging Research) to Trustees of Boston University to conduct the "Risk and Resilience, Clinical Presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The Diagnose CTE Research Project II." The project will retain and expand a longitudinal cohort of former football players and controls to examine the clinical and biomarker profiles of traumatic...
This Project Grant award, titled "Consequences of Exposure to Repetitive Head Impacts Across the Lifespan", is funded by the National Institute on Aging (CFDA 93.866 - Aging Research) for $4,269,339 from June 1, 2025 to May 31, 2027. The award is being provided to Trustees of Boston University Medical Campus to support research investigating the long-term clinical and neuropathological outcomes of repetitive head impact (RHI) exposure, particularly in relation to Alzheimer's disease,...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $843,248 project grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Trustees of Boston University's Medical Campus. The project aims to develop computational algorithms to accurately identify chronic traumatic encephalopathy (CTE) pathology and examine how repetitive head impacts (RHI) and other risk factors influence the regional distribution of...
This $459,076 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) aims to identify early transcriptional and pathological changes in vulnerable brain regions during the prodromal stage of Alzheimer's disease (AD). The primary awardee, Trustees of Boston University, will perform single-nucleus RNA sequencing and targeted mass spectrometry analyses on postmortem brain samples from individuals with early-stage AD pathology. This will yield a...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,592,854 to the University of Illinois to conduct research on tau protein conformation and its role in neurodegenerative diseases like Alzheimer's. The central hypothesis is that pathogenic forms of tau represent misregulation of normal tau functions as a scaffold for signaling pathways. The 2-year project aims to define the effects of tau post-translational modifications on tau function and...
This $866,723 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 Aging Research) to The Johns Hopkins University aims to improve understanding of the unique vulnerability of certain brain cell populations to Alzheimer's disease (AD) pathology. The grant will integrate high-field post-mortem brain imaging, histological analysis, and spatial transcriptomics to investigate how AD-related tau pathology and gene expression changes in the entorhinal cortex are associated...
This $7.72 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The Seattle Institute for Biomedical and Clinical Research will define the role of post-traumatic brain injury sleep disruption and glymphatic dysfunction in the development of Alzheimer's disease and chronic traumatic encephalopathy neuropathology. Over three years, the grantee and three sub-awardees will...
This Cooperative Agreement award, with a total funding amount of $1,122,294, was granted by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award will enable Trustees of Boston University, doing business as Boston University Medical Campus, to conduct research to determine the relationship between repetitive head impacts (RHI), traumatic brain injury...
This federal Project Grant award from the National Institute on Aging (NIA), under CFDA 93.866 Aging Research, provides $816,661 to The Regents of the University of California, San Francisco to conduct research on the molecular and cellular mechanisms by which pathological tau protein drives neurodegeneration in Alzheimer's disease (AD) and related tauopathies. The project will leverage expertise in mass spectrometry-based proteomics and functional genomics to comprehensively map the impact of...
This $784,596 Project Grant award, made under the National Institute on Aging's Aging Research program (CFDA 93.866), supports comprehensive proteogenomic profiling of aberrant and mis-processed proteins in Alzheimer's disease and tauopathy models at Northeastern University. The project aims to develop a state-of-the-art proteogenomic pipeline to globally profile disease-associated proteins with amino acid substitutions, alternative isoforms, post-translational modifications, and proteolytic...